FMR LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in CAPR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$23,488,528

-$3,138,687 QoQ

Shares Held

772,649

-16.3% QoQ

Ownership

1.33%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 98.86080225302823.ToString("F0")% Shared 0.ToString("F0")% None 1.1391977469717813.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,674,888,413 across 352 Biotechnology names. CAPR ranks #127 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$23,488,528	772,649	-16.3%	Shares	Defined	2026-05-15
2025-12-31	$26,627,215	922,634	+3794.6%	Shares	Defined	2026-02-17
2025-09-30	$170,804	23,690	-2.1%	Shares	Defined	2025-11-13
2025-06-30	$240,205	24,190	-2.3%	Shares	Defined	2025-08-14
2025-03-31	$234,934	24,756	+4.0%	Shares	Defined	2025-05-12
2024-12-31	$328,536	23,807	-2.2%	Shares	Defined	2025-02-13
2024-09-30	$370,272	24,344	+2434300.0%	Shares	Defined	2024-11-13
2024-03-31	$6	1	-97.5%	Shares	Defined	2024-05-13
2021-09-30	$160	40	0.0%	Shares	Defined	2022-02-14
2021-06-30	$205	40	-82.2%	Shares	Defined	2021-08-13
2021-03-31	$1,053	225	—	Shares	Defined	2021-05-14
No filing history on record for this holder in this stock.